Gaudium IVF And Women Health Ltd. IPO
IPO Timeline
-
20 Feb 2026Bidding Starts
-
24 Feb 2026Bidding Ends
-
25 Feb 2026Allotment Finalization
-
27 Feb 2026Listing
About Gaudium IVF And Women Health Ltd.
Our company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. Gaudium IVF is founded by our Promoter Dr. Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited. The company operates 30+ locations, which comprises of 7 hubs (centers) and 28 spokes (company has entered into a strategic alliance with Spokes i.e Infertility Expert to achieve the mutual goal of spreading awareness about ART and IVF treatment). Our treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI) and ovulation induction, all our treatment is carefully designed to address a variety of infertility challenges for both male and female.
Gaudium IVF And Women Health Ltd. IPO Reservation
| Investors Category | Shares Offered |
|---|---|
| Anchor Investors | 62,65,860 (30%) |
| Non Institutional Investors | 31,32,930 (15%) |
| Qualified Institutional Buyers (QIBs) | 41,77,240 (20%) |
| Retail Individual Investors (RIIs) | 73,10,170 (35%) |
Gaudium IVF And Women Health Ltd. Financial Information
| Year End | Revenue | PAT | Reserves & Surplus |
|---|---|---|---|
| 31 Mar 2026 | 72.08 Cr | 22.29 Cr | 112.87 Cr |
| 31 Mar 2025 | 59.24 Cr | 18.59 Cr | 14.74 Cr |
| 31 Mar 2024 | 46.20 Cr | 9.93 Cr | 25.67 Cr |
Gaudium IVF And Women Health Ltd. Background
-
2015Incorporation of the Company
-
2019Company started Gaudium Hospital
Company started Mumbai Center (Maharashtra)
-
2021Acquired the Gaudium IVF & Gynae Solutions, Proprietor Business of Dr. Manika Khanna:
* Janakpuri Center – opened in
-
2009* Greater Kailash Center – opened in
-
2016* Patna Center – opened in
-
2023Acquired Gaudium Brand
Acquired 100% shares of Gaudium International Private Limited
Acquired Gaudium Bawa Ludhiana Center**
Company started Bangalore Centre (Karnataka)
-
2024Company started Srinagar Centre (Jammu & Kashmir)
Conversion of company from Private to Public
1. Funding capital expenditure towards establishment of New IVF Centers of our Company
2. Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company
3. General Corporate Purposes
| Pricing Details | BSE | NSE |
|---|---|---|
| Issue Price | ₹ 79.00 | ₹ 79.00 |
| Open | ₹ 83.00 | ₹ 83.00 |
| Low | ₹ 79.05 | ₹ 79.50 |
| High | ₹ 87.15 | ₹ 87.15 |
| Last Trade | ₹ 80.48 | ₹ 80.26 |
1. Dr. Manika Khanna
2. Dr. Peeyush Khanna
3. Vishad Khanna
According to Infomerics Research Report, the global IVF market, valued at USD 27.49 billion in 2024, is projected to double to USD 54.60 billion by 2034 at a CAGR of 7.10%. India’s IVF market is set to grow faster, from USD 1.32 billion to USD 4.54 billion over the same period, at a CAGR of ... Read more
Phone no:8800028400
FAQs
When does Gaudium IVF And Women Health Ltd. IPO opens and closes?
Gaudium IVF And Women Health Ltd. IPO opens from 20th February to 24th February 2026.What is the size of Gaudium IVF And Women Health Ltd. IPO?
The size of the Gaudium IVF And Women Health Ltd. IPO is ₹165.00 Cr.What is the price range of Gaudium IVF And Women Health Ltd. IPO?
The price range of Gaudium IVF And Women Health Ltd. IPO is at ₹75 to ₹79 per share.What is the minimum investment and lot size required for the Gaudium IVF And Women Health Ltd. IPO?
The minimum investment required is ₹14,931 and minimum lot size is 189 shares.When is Gaudium IVF And Women Health Ltd. IPO listing date?
The Gaudium IVF And Women Health Ltd. IPO will be listed on 27th February 2026.What is the objective of Gaudium IVF And Women Health Ltd. IPO?
1. Funding capital expenditure towards establishment of New IVF Centers of our Company2. Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company
3. General Corporate Purposes
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article


Click it and Unblock the Notifications